The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...

For patients with certain types of advanced lung or skin cancer, administration of SARS-CoV-2 mRNA vaccine within 100 days of starting immune checkpoint inhibitors is associated with increased overall ...

University of Florida Health writer Michelle Jaffee reports a bold finding: cancer patients who got a COVID-19 mRNA vaccine ...

The journal Nature has reported that mRNA vaccines used to treat Covid-19 may prolong the lives of people with cancer who ...

Supported by the Center for Infectious Disease Research and Policy's (CIDRAP) Vaccine Integrity Project (VIP), the ...

A recent Associated Press investigation revealing hundreds of anti-science bills across the United States anchors this ...

This fall, with measles cases still spreading, there’s an additional challenge on top of the usual viral threat posed by COVID-19, RSV, influenza and the common cold. Here is the latest medical advice ...

How deep will the anti-science MAHA invasion penetrate into Mississippi? Can beleaguered state health officer Dr. Daniel ...

Moderna (NASDAQ:MRNA) stock surged as much as 12% Thursday following a STAT News report that the COVID-19 vaccine maker has been in discussions with at least one large pharmaceutical company about "a ...

A social media giant faltered on Thursday, Oct. 30, 2025, as a tax event weighed on its results, while a biotech name benefitted from reports of talks with a major pharma player.